Equilibrium adsorption of LDL and gold immunoconjugates to affinity membranes containing PEG spacers

Biomaterials

Volumn 21, Issue 1, 2000, Pages 37-48

  Soltys, Paul J ^a   Etzel, Mark R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Affinity; Immobilization; Immunoaffinity; Membrane; Poly(ethylene glycol)

Indexed keywords

ANTIBODY CONJUGATE; APOLIPOPROTEIN B; GOLD; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; MACROGOL;

ADSORPTION; ANTIBODY AFFINITY; ARTICLE; ARTIFICIAL MEMBRANE; COVALENT BOND; LIGAND BINDING; MEMBRANE BINDING; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; REACTION ANALYSIS;

ADSORPTION; CHROMATOGRAPHY, AFFINITY; GOLD; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; KINETICS; LIPOPROTEINS, LDL; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS;

EID: 0033990366     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00130-1     Document Type: Article

References (46)

1. Brandt S., Goffe R.A., Kessler S.B., O'Connor J.L., Zale S.E. Membrane based affinity technology for commercial scale purifications. Bio/Technology. 6:1988;779-782.
2. Hou K.C., Zaniewski R., Roy S. Protein A immobilized affinity cartridge for immunoglobulin purification. Biotechnol Appl Biochem. 13:1991;257-268.
3. Leckband D.E., Kuhl T., Wang H.K., Herron J., Muller W., Ringsdorf H. 4-4-20 Anti-fluorescyl IgG Fab′ recognition of membrane bound hapten. direct evidence for the role of protein and interfacial structure Biochemistry. 34:1995;11467-11478.
4. Holmberg K., Bergström K., Stark M.-B. Immobilization of proteins via PEG chains. Harris J.M. Poly(ethylene glycol) chemistry. biotechnical and biomedical applications:1992;Plenum Press, New York.
5. Sa da Costa V., Brier-Russell D., Trudel G., Waugh D.F., Salzman E.W., Merrill E.W. Polyether-polyurethane surfaces. thrombin adsorption, platelet adsorption, and ESCA scanning J Colloid Interface Sci. 76:1980;594-596.
6. Merrill E.W., Salzman E.W. Polyethylene oxide as a biomaterial. ASAIO J. 6:1983;60-64.
7. Hlady V., Wagenen R.A.V., Andrade J.D. Total internal reflection intrinsic fluorescence (TIRIF) spectroscopy applied to protein adsorption. Andrade J.D. Surface and interfacial aspects of biomedical polymers. vol. 2:1985;81-120 Plenum Press, New York.
8. Desai N.P., Hubbell J.A. Biological responses to polyethylene oxide modified polyethylene terephthalate surfaces. J Biomed Mater Res. 25:1991;829-843.
9. Lee J.H., Kopeckova P., Kopecek J., Andrade J.D. Surface properties of copolymers of alkyl methacrylates with methoxy(polyethylene oxide)methacrylates and their application as protein-resistant coatings. Biomaterials. 11:1990;455-464.
10. Gombotz W.R., Guanghui W., Horbett T.A., Hoffman A.S. Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res. 25:1991;1547-1562.
11. Nagaoka S., Mori Y., Takiuchi H., Yokota K., Tanzawa H., Nishiumi S. Interaction between blood components and hydrogels with poly(oxyethylene) chain. Polymer Preprints. 24:1983;67-68.
12. Sa da Costa V., Brier-Russell D., Salzman E.W., Merrill E.W. ESCA studies of polyurethanes. blood platelet activation in relation to surface composition J Colloid Interface Sci. 80:1981;445-452.
13. Deible C., Beckman E., Russell A., Wagner W. Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol. J Biomed Mater Res. 41:1998;251-256.
14. Klein E., Yeager D., Seshadri R., Baurmeister U. Affinity adsorption devices prepared from microporous poly(amide) hollow fibers and sheet membranes. J Membr Sci. 129:1997;31-46.
15. Tsuneda S., Saito K., Furusaki S., Sugo T. High-throughput processing of proteins using a porous and tentacle anion-exchange membrane. J Chromatogr A. 689:1995;211-218.
16. Tsuneda S., Shinano H., Saito K., Furusaki S., Sugo T. Binding of lysozyme onto a cation-exchange microporous membrane containing tentacle-type grafted polymer branches. Biotechnol Prog. 10:1994;76-81.
17. Olbricht C. Extracorporeal treatment of hypercholesterolemia. Nephrol Dial Transplant. 8:1993;814-820.
18. Richter W., Jacob B., Ritter M., Sühler K., Viernesiel K., Schwandt P. Three year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism. 42:1993;888-894.
19. Koll R. LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy. Therapeutic Apheresis. 2:1998;142-146.
20. Borberg H., Gaczkowski A., Hombach V., Oette K., Stoffel W. Treatment of familial hypercholesterolemia by means of specific immunoadsorption. J Clin Apheresis. 4:1988;59-65.
21. Wingard R.L., Lee W.O., Hakim R.M. Extracorporeal treatment of familial hypercholesterolemia with monoclonal antibodies to low-density lipoprotein. Am J Kidney Dis. 18:1991;559-565.
22. Kessler S.B. Adsorptive plasma treatment. optimization of extracorporeal devices and systems Blood Purif. 11:1993;150-157.
23. Blankstein L.A., Dohrman L. An advanced affinity membrane for immunodiagnostic tests. Am Clin Prod Rev. 11:1985;33-41.
24. Weiss A.J., McElhinney S.A., Blankstein L.A. The catalysis of protein and nucleic acid coupling to an affinity membrane substrate. BioTechniques. 7:1989;1012-1016.
25. du Moulin A. LDL immunoapheresis technique. In: Gotto A, Mancini M, Richter W, Schwandt, P, editors. Treatment of severe hypercholesterolemia in the prevention of coronary heart disease. Proceedings International Symposium Munich, 1989. Basel: Karger, 1990. p. 170-4.
26. Fasman G.D. Handbook of biochemistry and molecular biology. Proteins. 1976;CRC Press, Cleveland, Ohio.
27. O'Shannessy D.J., Wilchek M. Immobilization of glycoconjugates by their oligosaccharides. use of hydrazido-derivatized matrices Anal Biochem. 191:1990;1-8.
28. O'Shannessy D.J., Hoffman W.L. Site-directed immobilization of glycoproteins on hydrazide-containing solid supports. Biotechnol Appl Biochem. 9:1987;488-496.
29. Box G.E.P., Hunter W.G., Hunter J.S. Statistics for experimenters. 1978;Wiley, New York.
30. Bamford C.H., Al-Lamee K.G., Purbrick M.D., Wear T.J. Studies of a novel membrane for affinity separations. I. Functionalization and protein coupling. J Chromatogr. 606:1992;19-31.
31. Breslow J.L. Genetics of the human apolipoproteins. Scanu A.M., Spector A.A. Biochemistry and biology of plasma lipoproteins. 1986;85-119 Marcel Dekker Inc. New York.
32. Barter P.J., Rajaram O.V., Liang H-Q., Rye K-A. Relationship between the size and phospholipid content of low-density lipoproteins. Biochim Biophys Acta. 1166:1993;135-137.
33. Soltys PJ. Immunoaffinity membranes for extracorporeal treatment of hypercholesterolemia. University of Wisconsin - Madison, 1997.
34. Waldmann-Meyer H., Knippel E. A surface charge density model for structure and orientation of polymer-bound proteins. J Colloid Interface Sci. 148:1992;508-516.
35. Li J.T., Caldwell K.D., Rapoport N. Surface properties of pluronic-coated polymeric colloids. Langmuir. 10:1994;4475-4482.
36. Hiemenz PC. Polymer chemistry. New York: Marcel Dekker, 1984. p. 48-53.
37. Weast RC. CRC handbook of chemistry and physics. Boca Raton, FL: CRC Press, 1980. p. F218-21.
38. Young RJ. Introduction to polymers. London: Chapman & Hall Ltd., 1981. p. 89-95.
39. Harris J.M. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). Harris J.M. Poly(ethylene glycol) chemistry. biotechnical and biomedical applications:1992;1-14 Plenum Press, New York.
40. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981:1005-7.
41. Pascher A., Stangl M., Hammer C. Impact of immunoadsorption on complement activation, immunopathology, and hepatic perfusion during xenogeneic pig liver perfusion. Transplantation. 65:1998;737-740.
42. Gao C.L., Li B.A., Chen C.Z., Yu Y.T., Yuan P., Song J.C. Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy. Artif Organs. 19:1995;468-469.
43. Balint J. Immune modulation associated with extracorporeal immunoadsorption treatments utilizing protein A/silica columns. Artif Organs. 20:1996;906-913.
44. ® column for severe rheumatoid arthritis. J Clin Apheresis. 13:1998;90.
45. Regnault V., Rivat C., Marcillier P.et al. Study of parameters involved in specific immunoadsorption of apolipoprotein B. Int J Artif Organs. 13:1990;760-767.
46. Soltys P.J., Etzel M.R. In vitro characterization of a membrane-based low-density lipoprotein affinity adsorption device. Blood Purif. 16:1998;123-134.